Product
Tracleer
1 clinical trial
1 indication
Indication
Pulmonary Arterial HypertensionClinical trial
Randomized, Two-way, Two-period, Single Oral Dose, Open-label, Crossover, Bioequivalence Study to Compare Bosentan 32 mg Dispersible Tablets Versus Tracleer® 32 mg Tablets for Oral Suspension (Tracleer® 32 mg Dispersible Tablet) (Bosentan), in Healthy Subjects Under Fasting ConditionStatus: Completed, Estimated PCD: 2024-05-22